13F HOLDINGS REPORT
Octagon Capital Advisors LP
Quarter ended Q2 2025 · Filed August 14, 2025 · Accession 0001839435-25-000007
Total Value
$455.6M
Positions
30
Other Managers
0
Confidential Omitted
No
Holdings (30)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | DIANTHUS THERAPEUTICS INC | DNTH | 2,341,667 | $43.6M | 9.57% |
| 2 | ARRIVENT BIOPHARMA INC | AVBP | 1,946,054 | $42.4M | 9.30% |
| 3 | VERONA PHARMA PLC | 925050106 | 337,000 | $31.9M | 7.00% |
| 4 | TAYSHA GENE THERAPIES INC | TSHA | 12,592,500 | $29.1M | 6.38% |
| 5 | ARS PHARMACEUTICALS INC | SPRY | 1,350,000 | $23.6M | 5.17% |
| 6 | GOSSAMER BIO INC | GOSS | 18,350,000 | $22.6M | 4.95% |
| 7 | OCULAR THERAPEUTIX INC | OCUL | 2,425,000 | $22.5M | 4.94% |
| 8 | MERUS N V | N5749R100 | 389,000 | $20.5M | 4.49% |
| 9 | TREVI THERAPEUTICS INC | TRVI | 3,672,000 | $20.1M | 4.41% |
| 10 | COGENT BIOSCIENCES INC | COGT | 2,763,000 | $19.8M | 4.35% |
| 11 | ATYR PHARMA INC | ATYR | 3,820,000 | $19.4M | 4.25% |
| 12 | APELLIS PHARMACEUTICALS INC | APLS | 903,500 | $15.6M | 3.43% |
| 13 | NUVATION BIO INC | NUVB | 7,691,334 | $15.0M | 3.29% |
| 14 | TOURMALINE BIO INC | 89157D105 | 905,000 | $14.5M | 3.18% |
| 15 | KALVISTA PHARMACEUTICALS INC | KALV | 1,273,333 | $14.4M | 3.16% |
| 16 | MIND MEDICINE MINDMED INC | 60255C885 | 2,130,000 | $13.8M | 3.03% |
| 17 | CENTESSA PHARMACEUTICALS PLC | CNTA | 1,030,000 | $13.5M | 2.97% |
| 18 | PHARVARIS N V | PHVS | 672,595 | $11.8M | 2.60% |
| 19 | KYMERA THERAPEUTICS INC | KYMR | 266,000 | $11.6M | 2.55% |
| 20 | ABIVAX SA | AAVXF | 1,267,000 | $9.7M | 2.13% |
| 21 | DBV TECHNOLOGIES S A | DBVTF | 1,018,021 | $9.3M | 2.04% |
| 22 | CORBUS PHARMACEUTICALS HLDGS | CRBP | 1,115,000 | $7.7M | 1.69% |
| 23 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 148,000 | $7.0M | 1.53% |
| 24 | UNICYCIVE THERAPEUTICS INC | UNCY | 1,000,000 | $4.8M | 1.05% |
| 25 | NEUROGENE INC | NGNE | 303,000 | $4.5M | 0.99% |
| 26 | HELIX ACQUISITION CORP II | HLXC | 250,000 | $2.7M | 0.58% |
| 27 | MAZE THERAPEUTICS INC | MAZE | 177,667 | $2.2M | 0.48% |
| 28 | KALARIS THERAPEUTICS INC | KLRS | 360,000 | $961,200 | 0.21% |
| 29 | ERASCA INC | ERAS | 700,000 | $889,000 | 0.20% |
| 30 | NUVATION BIO INC | NUVB | 154,112 | $300,518 | 0.07% |